Exploring the use of Bimuno® GOS on traveller’s diarrhoea

Traveller’s diarrhoea (TD) is the most common cause of gastrointestinal (GI) issues encountered by those travelling in high-risk geographical areas (NICE., 2023). Whilst the prevalence of TD is dependent on the season of travel and destination, it is thought to affect up to 70% of traveller’s, particularly those visiting low or middle-income countries (NICE., 2023). Given the infectious nature of TD, modulation of the gut microbiome with prebiotics is an area of interest. In this Research Spotlight, we look at the effect of Bimuno® GOS on TD in healthy adults (Drakoularakou et al., 2010; Hasle et al., 2017).

The effects of Bimuno® GOS on athlete digestive health and immunity in a cohort of elite rugby union players

Elite rugby players endure high training loads that can lead to frequent upper respiratory and gastrointestinal issues. A recent study by Parker et al. (2023) investigated the impact of Bimuno® GOS, a prebiotic, on these health concerns. Explore the full details of the study on this article.

The effects of Bimuno® GOS on gut microbiome composition and immune function in older adults

The composition of intestinal microbiome differs as individuals age, resulting in decreases in beneficial gut bacteria, as well as showing declines to immune function (Aspinall and Andrew., 2000). As more research arises around gut health, a positive correlation between the presence of beneficial bacteria in the gut and immune function suggests gut microbiome modulation could support immunomodulatory capacity (Kelly-Quagliana et al., 2003; Hosono et al., 2003). 

In this research spotlight, we present a study looking at the effects of Bimuno® GOS on gut microbiome composition and immune function in an older adult population (Vulevic et al., 2008).